je.st
news
Declaratory Judgment Action Premature: Decision Suggests...
2014-12-09 23:40:26| Biotech - Topix.net
Biosimilar applicants and branded biologics have been wondering how the procedures set forth in the Biologics Price Competition and Innovation Act will be implemented since its enactment in 2010. The lack of guidance on this subject has already sparked litigation, including the recent litigation between Amgen Inc. and Sandoz Inc. discussed in our previous client alert, Left without a Partner: Amgen Sues Sandoz for Refusing to Dance in Accordance with BPCIA Patent Procedures .
Tags: action
decision
suggests
judgment
Category:Biotechnology and Pharmaceuticals